Massachusetts Medical Society

SHERPA: Blue

People

  1. Motzer
    Motzer
  2. Zauber
    Zauber
  3. Offit
    Offit
  4. Winawer
    Winawer
  5. Hudis
    Hudis
  6. Postow
    Postow
  7. Sepkowitz
    Sepkowitz
  8. Ladanyi
    Ladanyi
  9. Norton
    Norton
  10. Robson
    Robson

Groups

  1. Department of Medicine (327)
  2. Solid Tumor Oncology Division (209)
  3. GSK Faculty (112)
  4. Hematologic Malignancies, Division of (86)
  5. Center for Hematologic Malignancies (84)
  6. Population Sciences Research Program (80)
  7. Survivorship Research (76)
  8. Epidemiology and Biostatistics (65)
  9. Surgery (64)
  10. Sloan Kettering Institute Faculty (58)
Search Within
Formats
  1. Journal Article (517)
  2. Correspondence (27)
  3. Editorial (23)
  4. Research Letter (8)
  5. Review (4)
Groups
  1. Department of Medicine (327)
  2. Solid Tumor Oncology Division (209)
  3. GSK Faculty (112)
  4. Hematologic Malignancies, Division of (86)
  5. Center for Hematologic Malignancies (84)
  6. Population Sciences Research Program (80)

More Groups

People
  1. Robert Motzer (25)
  2. Jedd Wolchok (22)
  3. Peter Bach (18)
  4. Ann Zauber (15)
  5. Kenneth Offit (14)
  6. Sidney Winawer (14)

More People

Years
  1. 2025 (13)
  2. 2024 (16)
  3. 2023 (31)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (14)

More Years

Publications
  1. New England Journal of Medicine (574)
  2. NEJM Evidence (4)
  3. Cellular Therapy and Transplantation (1)

Results (579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML
    Journal Article

    DiNardo, C. D.; Stein, E. M.; de Botton, S.; Roboz, G. J.; Altman, J. K.; Mims, A. S.; Swords, R.; Collins, R. H.; Mannis, G. N.; Pollyea, D. A.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Phase 3 trial of Ibrutinib plus rituximab in Waldenström's macroglobulinemia
    Journal Article

    Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Orsucci, L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Neoadjuvant PD-1 blockade in resectable lung cancer
    Journal Article

    Forde, P. M.; Chaft, J. E.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Hellmann, M. D.; Zahurak, M.; Yang, S. C.; Jones, D. R.; Broderick, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden
    Journal Article

    Hellmann, M. D.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Otterson, G. A.; Audigier-Valette, C.; Minenza, E.; Linardou, H.; Burgers, S.; Salman, P.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation - To the editor
    Journal Article

    Gounder, M. M.; Solit, D. B.; Tap, W. D.
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia
    Journal Article

    Seymour, J. F.; Kipps, T. J.; Eichhorst, B.; Hillmen, P.; D'Rozario, J.; Assouline, S.; Owen, C.; Gerecitano, J.; Robak, T.; De La Serna, J.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Arén Frontera, O.; Melichar, B.; Choueiri, T. K.; Plimack, E. R.; Barthélémy, P.; Porta, C.; George, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Genetics and pathogenesis of diffuse large B-cell lymphoma
    Journal Article

    Schmitz, R.; Wright, G. W.; Huang, D. W.; Johnson, C. A.; Phelan, J. D.; Wang, J. Q.; Roulland, S.; Kasbekar, M.; Young, R. M.; Shaffer, A. L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Adverse events associated with immune checkpoint blockade - Reply
    Journal Article

    Postow, M. A.; Hellmann, M. D.
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children
    Journal Article

    Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save